5th Workshop on Dendritic Cell Biology: Anti-tumoral immunotherapy, from biology to the clinic
REGISTRATIONS ARE NOW OPEN TO THE:
5th Workshop on Dendritic Cell Biology:
Anti-tumoral immunotherapy, from biology to the clinic
27-29 March, 2019, Champalimaud Foundation, Lisbon, Portugal
Co-organised by Champalimaud Foundation (Lisbon) and Institut Curie (Paris)
This fifth workshop will focus on anti-tumor Immunotherapy. It consists in treating cancer by stimulating the immune system to efficiently attack tumor cells. The aim of this course is a better understanding of how the immune system actors including dendritic cells, detect and fight tumor cells and how their activities can be boosted. Speakers will include internationally renowned scientists that will provide a general overview of the basic, translational, and clinical research in the field.
Registration is free and open to all the members of the DCBIOL LabEx community (Institut Curie, Paris and CIML, Marseille), to the IMOCA industrial chair members and to international scientists and MDs working in the field (subscription of young scientists and MDs will be privileged). Students outside of the DBIOL LabEx will have to pay for flight tickets, hotel and dinners.
If you are a PALOP national working in a PALOP country (either as a researcher or medical doctor) you can apply for a grant financed by Fundação Calouste Gulbenkian.
For more information, please write to firstname.lastname@example.org
A student selection will be made based on CV and motivation.
To apply please click here
Application Deadline : 1 March 2019
Scientific Committee: Sebastian Amigorena (Institut Curie); Markus Maeurer (Champalimaud Foundation); Luís Moita (Instituto Gulbenkian Ciência); Emanuela Romano (Institut Curie) ; Bruno Santos (Instituto de Medicina Molecular); Henrique Veiga-Fernandes (Champalimaud Foundation)
Organising Committee: Nathalie Amzallag (Institut Curie); Elodie Mieville Penkova (Institut Curie); The Training Unit at Institut Curie (Joao Vilhena); Thiago Carvalho (Champalimaud Foundation)